# A Study of LY3041658 in Participants With Skin Diseases

> **NCT02896868** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 60 (estimated)

## Conditions studied

- Skin Diseases
- Psoriasis

## Interventions

- **DRUG:** LY3041658
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02896868
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-08
- **Primary completion:** 2019-03-19
- **Final completion:** 2019-03-19
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2019-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02896868

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02896868, "A Study of LY3041658 in Participants With Skin Diseases". Retrieved via MORVS 2026-10-16 from https://api.morvs.ai/clinical/NCT02896868. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*